Loading clinical trials...
Loading clinical trials...
Describe the efficacy of the use of topical besifloxacin in reducing the conjunctival microbiota as a prophylactic measure in patients scheduled for cataract surgery.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
NCT04570579 · Cataract, Cataract Senile, and more
NCT06483750 · Dry Eye Disease, Meibomian Gland Dysfunction, and more
NCT07297719 · Cataract Senile
NCT06479915 · Stroke, Microbial Disease
NCT05108675 · Weight Gain, Pregnancy, Microbial Colonization, and more
Institute of Ophthalmology, Conde de Valenciana Foundation
Mexico City, Mexico City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions